Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities

Virology

Volumn 299, Issue 1, 2002, Pages 72-87

  Kehmeier, Eva ^a   Rühl, Heiko ^a   Voland, Britta ^a   Conrad Stöppler, Melissa ^a   Androphy, Elliot ^b   Stöppler, Hubert ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Proteasome dependent protein degradation; Steady state HPV E6 protein level

Indexed keywords

PROTEIN E6; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER RISK; CELL LEVEL; CELL LINE; CONTROLLED STUDY; EUKARYOTE; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; SKIN EPITHELIUM; SKIN INFECTION; STEADY STATE; VERRUCA VULGARIS; VIRUS TYPING; WART VIRUS; WILD TYPE;

EUKARYOTA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS; VECTORS;

EID: 0036039798     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1502     Document Type: Article

References (67)

1. Retinoblastoma protein recruits histone deacetylase to repress transcription
2. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
3. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein
4. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences
5. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
6. Role of the LXCXE binding site in Rb function
7. Human pathogenic papillomavirus types: An update
8. Elevated wild-type p53 levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene
9. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential
10. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest
11. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
12. Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism
13. Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells
14. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation
15. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation
16. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins
17. Transformation of rat cells by DNA of human adenovirus 5
18. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
19. Telomerase activity, cell proliferation, and cancer
20. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
21. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase
22. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18
23. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53
24. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins
25. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing
26. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
27. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase
28. Telomerase activation by the E6 gene product of human papillomavirus type 16
29. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
30. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box
31. p53, the cellular gatekeeper for growth and division
32. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation
33. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides
34. p53 is a mediator for radiation-repressed human TR2 orphan receptor expression in MCF-7 cells, a new pathway from tumor suppressor to member of the steroid receptor superfamily
35. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells
36. Crisis intervention: The role of telomerase
37. The transforming activity of simian virus 40 large tumor antigen
38. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase
39. Mutational analysis of human papillomavirus type 16 E6 protein: Transforming function for human cells and degradation of p53 in vitro
40. The E6 protein of human papillomavirus type 16 binds to and inhibits coactivation by CBP and p300
41. Anatomy, taxonomy and evolution of papillomaviruses
42. HPV E6 targeted degradation of the discs large protein: Evidence for the involvement of a novel ubiquitin ligase
43. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression
44. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
45. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
46. PDZ domains bind carboxy-terminal sequences of target proteins
47. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53
48. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade
49. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
50. Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: A critical role of a retroviral Sp1-binding site
51. Can ends justify the means?: Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells
52. Regulation of the TRP Ca2+ channel by INAD in Drosophila photoreceptors
53. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis
54. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals
55. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis
56. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from maintenance of telomere length
57. The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA
58. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro
59. Association of insulin-like growth-factor-1-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells
60. Inhibition of Bak-induced apoptosis by HPV-18 E6
61. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types
62. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton
63. p53: Death star
64. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases
65. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300
66. Human papillomaviruses in the pathogenesis of human anogenital cancer
67. Papillomavirus infections - A major cause of human cancers